Anti-snoring Devices Market: Growth, Size, Share, and Trends

Report Code MD 3739
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Anti-snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, above 60), Distribution Channel (Online, Retail), End User (Homecare, Hospital) - Global Forecast to 2029

Overview

The global anti-snoring devices market, valued at US$0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$0.91 billion in 2024 and an impressive US$1.45 billion by 2029.

The anti-snoring devices market is expected to grow due to factors such as the increasing prevalence of sleep disorders like sleep apnea; advancements in sleep therapy technologies; and the expanding aging population with the subsequent increase in chronic conditions. Additionally, the increasing rates of obesity along with the growing consumption of alcohol & cigarettes among people are other factors expected to contribute to market growth. Moreover, innovations in oral appliance technology and enhanced features for regularized patient compliance are expected to provide significant opportunities for market growth during the forecast period by improving patient compliance and encouraging adoption.

The fastest-growing device segment is the oral appliances segment, which includes mandibular advancement devices (MADs) and tongue-retaining/stabilizing devices (TRDs). The large share of the oral appliances segment can be attributed to the growing awareness among healthcare providers & patients regarding the cost-efficiency and easy availability of oral appliances. Additionally, government initiatives promoting awareness about snoring and untreated sleep apnea are expected to improve diagnosis rates and boost the demand for anti-snoring devices.

Anti-snoring Devices Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Anti-snoring Devices Market

Asia Pacific

The high growth rate of the Asia Pacific region can be attributed to the rising incidence of snoring; expansion of geriatric population; the high growth potential of emerging markets; and rising technological innovations in anti-snoring devices.

The market is driven by the growing prevalence of sleep disorders globally coupled with the favorable government initiatives for the ill effects of untreated OSA.

Growing awareness and an increasing number of innovative sleep apnea oral appliances are expected to boost the demand for anti-snoring devices across North America and the Asia Pacific region.

The Asia Pacific anti-snoring devices market is expected to be worth USD 0.55 billion by 2029, growing at the highest CAGR of 13.6% during the forecast period.

Product launches and partnerships were the most widely adopted growth strategies by market players.

Global Anti-snoring Devices Market Dynamics

DRIVER: Growing prevalence of sleep disorders

Although highly prevalent in the elderly, sleep disorders such as obstructive sleep apnea, snoring, and sleep apnea affect people of all ages and are some of the most common sleep disorders globally. The health impact of snoring is quite substantial but under-recognized.

In 2024, a study published in the Journal of Clinical Medicine reported that obstructive sleep apnea (OSA) is widespread among individuals aged 30–69. According to Benjafield et al., the global prevalence of OSA is almost 1 billion people affected, with the rate of OSA exceeding 50% in some countries. According to an article published by the European Respiratory Society in 2022, OSA is a widespread chronic condition that impacts over 20% of adults. According to a study published in the American Journal of Respiratory and Critical Care Medicine in 2021, the global prevalence of OSA was 22.6%. Changing lifestyles also contribute to the worldwide rise in obesity prevalence, which is likely to increase the snoring patient pool significantly. This expanding pool of patients offers a high growth opportunity for the anti-snoring devices market.

RESTRAINT: High price of customized oral appliances

Oral appliances are typically customized to fit a patient's dental structure. Over-the-counter (OTC) appliances can lead to issues such as excessive salivation, discomfort when biting, changes in how the teeth come together, tooth pain, and temporomandibular disorders (TMD). Therefore, customized appliances are often preferred due to these potential drawbacks.

However, customized products are more expensive. For instance, a customized oral sleep apnea device typically costs between USD 1,200 and USD 2,500, including the device, dentist visits, follow-ups for adjustments, and device modifications. A CPAP device costs between USD 500 and USD 3,000, with an average price of around USD 850 (Source: American Sleep Association). Regular annual and bi-annual checkups are also necessary, increasing the overall treatment cost. Furthermore, neither the patient nor the prescribing doctor can predict the effectiveness of oral therapy with certainty, even after spending a significant amount on the treatment. This uncertainty is expected to have a negative impact on the overall growth of the anti-snoring devices market.

 

OPPORTUNITY: High-growth potential of emerging economies

The anti-snoring treatment market in emerging markets is still nascent due to the limited awareness about sleep disorders and available treatments. Also, the high cost of some anti-snoring devices significantly limits their adoption in developing countries. However, this scenario is expected to change as healthcare delivery in developing countries slowly transitions from curative medicine to wellness and prevention. Moreover, the mindset of urban patients in developing economies is changing, and they are focusing more on managing their wellness than treating illnesses.

In the coming years, the growth of the anti-snoring treatment market will be centered in countries like China, India, Singapore, Hong Kong, and Brazil. Growth in many of these markets will also be fueled by the rising prevalence of cardiovascular diseases, hypertension, Type II diabetes, and stroke, which are closely linked to sleep-related disorders such as snoring and apnea. Increasing adoption of Western food habits, sedentary lifestyles, and lack of exercise are the primary factors responsible for continuous growth in obesity rates in several emerging economies.

CHALLENGES: Complex referral pathways and long waiting periods

The referral channel from primary care physicians (PCPs) to sleep specialists and then to Durable Medical Equipment (DME) divisions, home healthcare dealers, or dental practitioners often creates bottlenecks for the accurate diagnosis and follow-up treatment of OSA. Most patients do not have the patience for such lengthy referral processes, leading to delayed diagnosis.

Other factors, such as the shortage of dental professionals; lack of training and awareness regarding sleep apnea & snoring among dentists and primary care physicians; and a severe shortage of well-equipped sleep centers, also deter the effective diagnosis and management of sleep apnea. The journey for diagnosis & therapy can be exhaustive, involving multiple medical visits and incurring high costs, which creates a significant challenge for patients.

Global Anti-snoring Devices Market Ecosystem Analysis

The anti-snoring devices market ecosystem involves various stakeholders and technologies.

Anti-snoring Devices Market
 

By device type, the oral appliances segment accounted for the largest share of the market in 2023

The anti-snoring devices market, categorized by device type, includes oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, the oral appliances segment accounted for the largest market share, primarily due to the growing popularity of mandibular advancement devices (MADs). This dominance is supported by extensive research demonstrating its superior effectiveness to other anti-snoring solutions.

By end user, the home care settings segment dominated the anti-snoring devices market in 2023

By end user, the anti-snoring devices market is segmented into home care settings and hospitals & clinics. The home care settings segment accounted for the largest share of the anti-snoring devices market in 2023. The large share of this segment can be attributed to the increasing patient preference for home sleep testing and the growing number of advanced home sleep care devices available in the market.

In 2023, North America accounted for the largest share of the anti-snoring devices market

The market for anti-snoring devices has been segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. In 2023, North America accounted for the largest share of the market. The large share of the market is driven by the high healthcare expenditure; increasing prevalence of sleep apnea and snoring; and the rising demand for alternative treatments owing to poor adherence to CPAP therapy. Established regulatory frameworks and stringent regulatory guidelines for product approval in the anti-snoring devices market are expected to contribute to the demand for technologically advanced products, thus fueling market growth.

HIGHEST CAGR MARKET IN 2023
NORTH AMERICA FASTEST GROWING MARKET IN THE REGION
Anti-snoring Devices Market

Recent Developments of Anti-snoring Devices Market

  • In November 2023, Vivos (US) obtained 510(k) clearance from the US FDA in December 2022 for the Daytime Nighttime Appliance (DNA appliance) as a Class II medical device. This appliance treats snoring and mild-to-moderate OSA in adults.
  • In May 2023, ResMed (US) acquired Somnoware, a US-based sleep & respiratory care diagnostics software leader.

Key Market Players

KEY PLAYERS IN THE ANTI-SNORING DEVICES MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Anti-snoring Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Device type, gender, age group, distribution channel, end user, and region
Geographies covered North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries

 

Key Questions Addressed by the Report

What are the recent trends affecting the anti-snoring devices market?
The recent trends in the anti-snoring devices market include the rising prevalence of sleep disorders like sleep apnea, advancements in sleep therapy technologies, and the increasing geriatric population, which is often associated with a higher incidence of chronic diseases.
What are the leading types of anti-snoring devices?
The anti-snoring devices market, categorized by device type, includes oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, the oral appliances segment accounted for the largest market share due to the growing popularity of mandibular advancement devices (MADs). This dominance is supported by extensive research demonstrating their superior effectiveness to other anti-snoring solutions.
Who are the key players in the anti-snoring devices market?
The leading market players include F. Hoffmann-La Roche Ltd. (Switzerland), LabCorp Inc. (US), Guardant Health (US), Sysmex Corporation (Japan), NeoGenomics Laboratories, Inc. (US), Adaptive Biotechnologies Corporation (US), and Bio-Rad Laboratories, Inc. (US), among others.
What are the primary distribution channels of anti-snoring devices?
Classified by distribution channels, the anti-snoring devices market includes online, retail, and hospital pharmacies. In 2023, the retail pharmacies segment held the largest market share. The growth in this segment is driven by the convenience, affordability, and easy accessibility offered by these channels, making them a preferred choice for consumers.
Which region is lucrative for the growth of the anti-snoring devices market?
The Asia Pacific region is one of the leading anti-snoring device markets, primarily due to the high prevalence of snoring and OSA; the large patient population; and advancements in healthcare infrastructure.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Anti-snoring Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
30
  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    MARKET SEGMENTATION
    INCLUSIONS & EXCLUSIONS
    YEARS CONSIDERED
    CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
RESEARCH METHODOLOGY
35
  • 2.1 RESEARCH DATA
    SECONDARY DATA
    - Key data from secondary sources
    PRIMARY DATA
    - Primary sources
    - Key industry insights
    - Key data from primary sources
    - Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    BOTTOM-UP APPROACH
    - Approach 1: Company revenue estimation approach
    - Approach 2: Presentations of companies and primary interviews
    - Approach 3: Patient-based approach
    - Growth forecast
    - CAGR projections
    TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ASSUMPTIONS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT
EXECUTIVE SUMMARY
48
PREMIUM INSIGHTS
52
  • 4.1 ANTI-SNORING DEVICES MARKET OVERVIEW
  • 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES
MARKET OVERVIEW
56
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing prevalence of sleep disorders
    - Increasing geriatric population and subsequent rise in obesity
    - Growing cigarette & alcohol consumption
    - Rising technological advancements in anti-snoring devices
    RESTRAINTS
    - High price of customized oral appliances
    - Unreliable efficacy and inadequate studies for utilization of anti-snoring devices
    - Social stigma associated with snoring
    OPPORTUNITIES
    - Expanding undiagnosed population
    - High growth potential of emerging markets
    CHALLENGES
    - Complex referral pathways and long waiting periods
  • 5.3 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
    AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023
    AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021–2023 (USD)
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Mandibular advancement devices
    ADJACENT TECHNOLOGIES
    - Daytime-nighttime appliances
  • 5.10 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019–2023 (USD MILLION)
    EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019–2023 (USD MILLION)
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES & EVENTS, 2024−2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 CASE STUDY ANALYSIS
ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE
87
  • 6.1 INTRODUCTION
  • 6.2 ORAL APPLIANCES
    MANDIBULAR ADVANCEMENT DEVICES
    - Ready-made mandibular advancement devices
    - Custom-made mandibular advancement devices
  • 6.3 TONGUE-RETAINING/STABILIZING DEVICES
    LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET
  • 6.4 NASAL DEVICES
    EXTERNAL NASAL DILATORS
    - Convenient and non-invasive benefits to boost demand
    OTHER NASAL DEVICES
  • 6.5 POSITION CONTROL DEVICES
  • 6.6 CHIN STRAPS
  • 6.7 EPAP THERAPY DEVICES
ANTI-SNORING DEVICES MARKET, BY GENDER
117
  • 7.1 INTRODUCTION
  • 7.2 MALE PATIENTS
    HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS TO PROPEL MARKET
  • 7.3 FEMALE PATIENTS
    RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET
ANTI-SNORING DEVICES MARKET, BY AGE GROUP
123
  • 8.1 INTRODUCTION
  • 8.2 BELOW 40 YEARS
    LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS TO RESTRAIN MARKET
  • 8.3 BETWEEN 40–60 YEARS
    INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET
  • 8.4 ABOVE 60 YEARS
    CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH
ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
132
  • 9.1 INTRODUCTION
  • 9.2 ONLINE PHARMACIES
    GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
  • 9.3 RETAIL PHARMACIES
    CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET
  • 9.4 HOSPITAL PHARMACIES
    GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE
ANTI-SNORING DEVICES MARKET, BY END USER
140
  • 10.1 INTRODUCTION
  • 10.2 HOME CARE SETTINGS
    GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET
  • 10.3 HOSPITALS & CLINICS
    RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
ANTI-SNORING DEVICES MARKET, BY REGION
146
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Rising trend of remote sleep testing to fuel uptake
    CANADA
    - Increasing number of research grants for sleep apnea devices to boost demand
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - High prevalence of smoking to boost demand
    UK
    - Rising awareness and increasing number of sleep service groups to support market growth
    FRANCE
    - Rising geriatric population to fuel uptake
    ITALY
    - Favorable initiatives for treatment of OSA to support market growth
    SPAIN
    - Increasing initiatives for social awareness by regional organizations for treatment to drive market
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Growing adult obesity rates and expanding geriatric population to propel market
    JAPAN
    - Rising demand for cloud-connected OSA therapy devices to boost demand
    AUSTRALIA
    - Rising R&D initiatives for innovative sleep therapy devices to boost demand
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Favorable reimbursement policies for advanced sleep apnea procedures to drive market
    MEXICO
    - Poor healthcare infrastructure to limit market growth
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    HIGH OBESITY RATES TO SUPPORT MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
225
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET
  • 12.3 REVENUE ANALYSIS, 2019–2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
    RANKING OF KEY MARKET PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Device footprint
    - Distribution channel footprint
    - End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
243
  • 13.1 KEY PLAYERS
    RESMED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SOMNOMED
    - Business overview
    - Products offered
    - MnM view
    PROSOMNUS SLEEP TECHNOLOGIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VIVOS THERAPEUTICS, INC.
    - Business overview
    - Products offered
    - Recent developments
    DYNAFLEX
    - Business overview
    - Products offered
    - Recent developments
    OPENAIRWAY
    - Business overview
    - Products offered
    - Recent developments
    PANTHERA DENTAL
    - Business overview
    - Products offered
    - Recent developments
    AIRWAY MANAGEMENT
    - Business overview
    - Products offered
    - Recent developments
    APNEA SCIENCES
    - Business overview
    - Products offered
    ORAVANOSA
    - Business overview
    - Products offered
    MYERSON LLC
    - Business overview
    - Products offered
    BRAEBON MEDICAL CORPORATION
    - Business overview
    - Products offered
  • 13.2 OTHER PLAYERS
    MPOWRX HEALTH & WELLNESS PRODUCTS
    THE SNORE RELIEVER COMPANY, LLC
    TOMED GMBH
    THE AURUM GROUP
    OSCIMED SA
    SICAT GMBH & CO. KG
    GLIDEWELL
    APNOMED, INC.
    ZQUIET
    DREAM SYSTEMS DENTAL SLEEP LAB
    PURE SLEEP COMPANY
    THERAVENT, INC.
    INNOVATIVE HEALTH TECHNOLOGIES
APPENDIX
272
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 ANTI-SNORING DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 ANTI-SNORING DEVICES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022–2024
  • TABLE 4 KEY STATISTICS ON AGING POPULATION
  • TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SNORING
  • TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA AND SNORING
  • TABLE 7 INADEQUATE EFFICACY STUDIES ASSOCIATED WITH USE OF ANTI-SNORING DEVICES
  • TABLE 8 KEY STATISTICS ON SNORING POPULATION
  • TABLE 9 HIGH GROWTH POTENTIAL IN EMERGING MARKETS DUE TO UNDIAGNOSED POPULATION
  • TABLE 10 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
  • TABLE 11 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023
  • TABLE 12 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021–2023 (USD)
  • TABLE 13 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024−2025
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES (%)
  • TABLE 25 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES
  • TABLE 26 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 27 ORAL APPLIANCES OFFERED BY KEY PLAYERS
  • TABLE 28 ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 ORAL APPLIANCES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 32 EUROPE ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 EUROPE: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 34 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 36 LATIN AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 38 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 39 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 45 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 LATIN AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 51 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 LATIN AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS
  • TABLE 57 TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 EUROPE: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 63 NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 EUROPE: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 LATIN AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 EXTERNAL NASAL DILATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 EUROPE: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 OTHER NASAL DEVICES
  • TABLE 74 OTHER NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 EUROPE: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 LATIN AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 POSITION CONTROL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 EUROPE: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 CHIN STRAPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 EUROPE: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 LATIN AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 EPAP THERAPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 PREVALENCE OF SLEEP APNEA, BY AGE GROUP AND GENDER
  • TABLE 95 ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 96 ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 PREVALENCE OF SLEEP APNEA, BY AGE GROUP (2022)
  • TABLE 107 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 108 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: 40–60 YEARS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 124 ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 140 ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 141 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 146 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 ANTI-SNORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 152 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 158 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 160 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 161 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN US
  • TABLE 162 US: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 US: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 US: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 US: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 167 US: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 168 US: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 169 US: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 170 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN CANADA
  • TABLE 171 CANADA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 CANADA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 CANADA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 176 CANADA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 177 CANADA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 178 CANADA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 179 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 180 EUROPE: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 186 EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 187 EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 188 EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 189 ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN GERMANY
  • TABLE 190 GERMANY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 GERMANY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 GERMANY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 195 GERMANY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 196 GERMANY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 197 GERMANY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 198 UK: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 UK: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 UK: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 203 UK: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 204 UK: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 205 UK: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 206 MAJOR PLAYERS THAT ARE REIMBURSED BY SOCIAL SECURITY OF FRANCE
  • TABLE 207 FRANCE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 FRANCE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 FRANCE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 212 FRANCE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 213 FRANCE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 214 FRANCE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 215 ITALY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 ITALY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 ITALY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 220 ITALY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 221 ITALY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 222 ITALY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 223 SPAIN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 SPAIN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 SPAIN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 228 SPAIN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 229 SPAIN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 230 SPAIN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 REST OF EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 238 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 240 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 249 CHINA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 CHINA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 CHINA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 254 CHINA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 255 CHINA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 256 CHINA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 257 JAPAN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 JAPAN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 JAPAN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 262 JAPAN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 263 JAPAN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 264 JAPAN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 265 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 AUSTRALIA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 270 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 271 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 272 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 273 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 282 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 291 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 BRAZIL: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 BRAZIL: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 BRAZIL: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 296 BRAZIL: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 297 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 298 BRAZIL: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 299 MEXICO: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 MEXICO: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 MEXICO: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 MEXICO: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 304 MEXICO: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 305 MEXICO: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 306 MEXICO: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 307 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 REST OF LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 312 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 313 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 314 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 315 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 316 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 MIDDLE EAST & AFRICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 321 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 322 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 323 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 324 GCC COUNTRIES: MACROECONOMIC INDICATORS
  • TABLE 325 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 GCC COUNTRIES: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 330 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 331 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)
  • TABLE 332 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 333 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ANTI-SNORING DEVICE MANUFACTURING COMPANIES
  • TABLE 334 ANTI-SNORING DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 335 ANTI-SNORING DEVICES MARKET: REGION FOOTPRINT
  • TABLE 336 ANTI-SNORING DEVICES MARKET: DEVICE FOOTPRINT
  • TABLE 337 ANTI-SNORING DEVICES MARKET: DISTRIBUTION CHANNEL FOOTPRINT
  • TABLE 338 ANTI-SNORING DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 339 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 340 ANTI-SNORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 341 ANTI-SNORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 342 ANTI-SNORING DEVICES MARKET: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 343 ANTI-SNORING DEVICES MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 344 ANTI-SNORING DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 345 RESMED: COMPANY OVERVIEW
  • TABLE 346 RESMED: PRODUCTS OFFERED
  • TABLE 347 RESMED: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 348 RESMED: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 349 SOMNOMED: COMPANY OVERVIEW
  • TABLE 350 SOMNOMED: PRODUCTS OFFERED
  • TABLE 351 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 352 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 353 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 354 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 355 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED
  • TABLE 356 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–MARCH 2024
  • TABLE 357 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 358 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 359 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 360 DYNAFLEX: COMPANY OVERVIEW
  • TABLE 361 DYNAFLEX: PRODUCTS OFFERED
  • TABLE 362 DYNAFLEX: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 363 OPENAIRWAY: COMPANY OVERVIEW
  • TABLE 364 OPENAIRWAY: PRODUCTS OFFERED
  • TABLE 365 OPENAIRWAY: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 366 PANTHERA DENTAL: COMPANY OVERVIEW
  • TABLE 367 PANTHERA DENTAL: PRODUCTS OFFERED
  • TABLE 368 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 369 PANTHERA DENTAL: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 370 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 371 AIRWAY MANAGEMENT: COMPANY OVERVIEW
  • TABLE 372 AIRWAY MANAGEMENT: PRODUCTS OFFERED
  • TABLE 373 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021−NOVEMBER 2024
  • TABLE 374 APNEA SCIENCES: COMPANY OVERVIEW
  • TABLE 375 APNEA SCIENCES: PRODUCTS OFFERED
  • TABLE 376 ORAVANOSA: COMPANY OVERVIEW
  • TABLE 377 ORAVANOSA: PRODUCTS OFFERED
  • TABLE 378 MYERSON LLC: COMPANY OVERVIEW
  • TABLE 379 MYERSON LLC: PRODUCTS OFFERED
  • TABLE 380 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
  • TABLE 381 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 MARKETS & REGIONS COVERED
  • FIGURE 2 ANTI-SNORING DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 ANTI-SNORING DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 ANTI-SNORING DEVICES MARKET: STUDY ASSUMPTIONS
  • FIGURE 10 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 ANTI-SNORING DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 INCREASING INCIDENCE OF SLEEP DISORDERS TO PROPEL MARKET
  • FIGURE 17 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 ORAL APPLIANCES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 23 ANTI-SNORING DEVICES MARKET: ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 24 ANTI-SNORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
  • FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • FIGURE 27 ANTI-SNORING DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ANTI-SNORING DEVICES PATENTS, JANUARY 2014—MARCH 2024
  • FIGURE 30 ANTI-SNORING DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES
  • FIGURE 32 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES
  • FIGURE 33 ANTI-SNORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2019−2024)
  • FIGURE 34 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2021−2023 (USD MILLION)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET (2023)
  • FIGURE 38 RANKING OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2023
  • FIGURE 39 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 ANTI-SNORING DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 41 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 ANTI-SNORING DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 RESMED: COMPANY SNAPSHOT (2024)
  • FIGURE 46 SOMNOMED: COMPANY SNAPSHOT (2023)
  • FIGURE 47 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)
  • FIGURE 48 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023)

 

This study involved four major activities in estimating the current size of the anti-snoring devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Anti-snoring Devices Market

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
SomnoMed (Australia) General Manager
ResMed (US) Area Sales Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the anti-snoring devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the anti-snoring devices market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

The research methodology used to estimate the market size includes the following:

Anti-snoring Devices Market

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Anti-snoring devices are tools or apparatuses designed to reduce or eliminate snoring by addressing its underlying causes. Snoring occurs due to the vibration of tissues in the throat or nasal passages during sleep, often caused by partial airway obstruction. These devices promote better airflow, reduce airway obstructions or reposition anatomical structures.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department 
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the global anti-snoring devices market by device type, gender, age, distribution channel, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall anti-snoring devices market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC.
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches, agreements, partnerships, and acquisitions in the anti-snoring devices market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Previous Versions of this Report

Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others (Septoplasty, ESS)) - Global Trends & Forecast to 2020

Report Code MD 3739
Published in Sep, 2015, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Anti-snoring Devices Market

DMCA.com Protection Status